On March 4th, the U.S. Patent and Trademark Office issued new guidelines on patent eligibility for subject matter derived from nature following the U.S. Supreme Court’s decisions in Myriad and Prometheus. Finnegan attorney Leslie McDonell discusses the new USPTO guidelines and the potential impact on the biotech and natural products industries.